+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice

A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice

Infection and Immunity 73(1): 325-333

Increasing antibiotic resistance and a rising patient population at risk for infection due to impaired immunity underscore the importance of vaccination against pneumococci. However, available capsular polysaccharide vaccines are often poorly immunogenic in patients at risk for pneumococcal disease. The goal of this study was to explore the potential of peptide mimotopes to function as alternative vaccine antigens to elicit a type-specific antibody response to pneumococci. We used a human monoclonal immunoglobulin A (IgA) antibody (NAD) to type 8 Streptococcus pneumoniae capsular polysaccharide (type 8 PS) to screen a phage display library, and the phage PUB1 displaying the peptide FHLPYNHNWFAL was selected after three rounds of biopanning. Inhibition studies with phage-displayed peptide or the peptide PUB1 and type 8 PS showed that PUB1 is a mimetic of type 8 PS. PUB1 conjugated to tetanus toxoid (PUB1-TT) induced a type 8 PS-specific antibody response in BALB/c mice, further defining it as a mimotope of type 8 PS. The administration of immune sera obtained from PUB1-TT-immunized mice earlier (days 14 and 21) and later (days 87 and 100) after primary and reimmunization resulted in a highly significant prolongation of the survival of naive mice after pneumococcal challenge compared to controls. The survival of PUB1-TT-immunized mice was also prolonged after pneumococcal challenge nearly 4 months after primary immunization. The efficacy of PUB1-TT-induced immune sera provides proof of principle that a mimotope-induced antibody response can protect against pneumococci and suggests that peptide mimotopes selected by type-specific human antibodies could hold promise as immunogens for pneumococci.

(PDF emailed within 0-6 h: $19.90)

Accession: 013070239

Download citation: RISBibTeXText

PMID: 15618169

DOI: 10.1128/IAI.73.1.325-333.2005

Related references

Vaccination with a peptide mimotope of S pneumoniae serotype 8 capsular polysaccharide protects Balb/c mice against a systemic pneumococcal infection. Abstracts of the General Meeting of the American Society for Microbiology 103: E-026, 2003

Peptide mimotopes of pneumococcal capsular polysaccharide of 6B serotype: a peptide mimotope can bind to two unrelated antibodies. Journal of Immunology 168(12): 6273-6278, 2002

Dendritic cell-derived exosomes express a Streptococcus pneumoniae capsular polysaccharide type 14 cross-reactive antigen that induces protective immunoglobulin responses against pneumococcal infection in mice. Infection and Immunity 75(1): 220-230, 2006

Induction of a protective capsular polysaccharide antibody response to a multiepitope DNA vaccine encoding a peptide mimic of meningococcal serogroup C capsular polysaccharide. Immunology 110(2): 242-249, October, 2003

An evolutionary phage display sublibrary reveals a peptide mimotope of the polysaccharide capsule of Cryptococcus neoformans that elicits a high-titer protective response in mice. FASEB Journal 14(6): A947, April 20, 2000

Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. Infection and Immunity 72(1): 196-208, 2003

The regulation of the immune response of mice to Haemophilus influenzae type b capsular polysaccharide. Immunology 34(1): 149-156, 1978

Modulation of the immune response to pneumococcal type 14 capsular polysaccharide-protein conjugates by the adjuvant Quil A depends on the properties of the conjugates. Infection and Immunity 57(4): 1078-1083, 1989

Genetic control of the immune response of mice to type III pneumococcal polysaccharide. Cellular Immunology 10(2): 280-286, 1974

Mechanism of protective effect of a monoclonal antibody to type 7f pneumococcal capsular polysaccharide. Clinical Research 33(4): 843A, 1985

Pneumococcal 6-phosphogluconate-dehydrogenase, a putative adhesin, induces protective immune response in mice. Clinical and Experimental Immunology 144(2): 254-263, 2006

Protective levels of polysaccharide-specific maternal antibodies may enhance the immune response elicited by pneumococcal conjugates in neonatal and infant mice. Infection and Immunity 73(2): 956-964, 2005

Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide. Infection and Immunity 73(11): 7311-7316, 2005